Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     
  • Bitcoin GBP

    51,605.66
    +526.07 (+1.03%)
     
  • CMC Crypto 200

    1,369.53
    +56.90 (+4.34%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

What to Expect from AstraZeneca’s Second-Quarter Earnings

What to Expect from AstraZeneca’s Second-Quarter Earnings

AstraZeneca (AZN), the maker of key products like Lynparza, Tagrisso, Imfinzi, Brilinta, and Farxiga, is expected to report Q2 2018 earnings on July 26. AstraZeneca’s revenues are expected to increase 0.77% from $5.05 billion in Q2 2017 to $5.09 billion in Q2 2018. In fiscal 2017, AstraZeneca generated $22.46 billion in revenues.